Journals / Turkish Journal of Pediatrics / 2015 / Cilt: 57 - Sayı: 3

A pediatric case of acute meningitis due to Streptococcus pneumoniae serotype 33D

Pages
304–307
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we present a pediatric case of meningitis due to S. pneumoniae serotype 33D, which has not been previously identified as a cause of IPD in those countries where PCV7 is routinely administered, including Turkey.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Streptococcus pneumoniae is a leading cause of bacterial meningitis in children.
📊
Key Findings & Data:The serotypes included in the 7-valent conjugated pneumococcal vaccine (PCV7)--1, 5, 6A, 6B, 14, 19F, 23F--are those most commonly responsible for invasive pneumococcal disease (IPD) globally.
💡
Conclusion & Impact:In this report, we present a pediatric case of meningitis due to S. pneumoniae serotype 33D, which has not been previously identified as a cause of IPD in those countries where PCV7 is routinely administered, including Turkey.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Streptococcus pneumoniae is a leading cause of bacterial meningitis in children. It is also responsible for bacteremia, sepsis, pneumonia, sinusitis and acute otitis media in young children worldwide. The serotypes included in the 7-valent conjugated pneumococcal vaccine (PCV7)--1, 5, 6A, 6B, 14, 19F, 23F--are those most commonly responsible for invasive pneumococcal disease (IPD) globally. Unvaccinated children are at greater risk for meningitis. The rate of non-vaccine serotypes as causes of invasive disease has increased. Although the incidence rate of IPD is highest in children aged <2 years, the rare, non-vaccine serotypes of S. pneumoniae may be responsible for acute meningitis in older, unvaccinated children. In this report, we present a pediatric case of meningitis due to S. pneumoniae serotype 33D, which has not been previously identified as a cause of IPD in those countries where PCV7 is routinely administered, including Turkey.

🔖

Cite This Article

KAMAN, A., AYDIN-TEKE, T., ÖZ, F. N., BAYHAN, G. İ., AKCAN, Ö. M., AYDIN, Z. G. G., TANIR, G. (2015). A pediatric case of acute meningitis due to Streptococcus pneumoniae serotype 33D. Turkish Journal of Pediatrics, Cilt: 57 - Sayı: 3, 304–307. https://ajindex.com/articles/412289

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010; 125: 1020-1030
  2. Echtler K, Stark K, Lorenz M, et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 2010; 16: 75-82
  3. Clyman R, Chemtob S. Vessel remodeling in the newborn: platelets fill the gap. Nat Med 2010; 16: 33-35
  4. Shah NA, Hills NK, Waleh N, et al. Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment. J Pediatr 2011; 158: 919-923
  5. Alyamac Dizdar E, Ozdemir R, Sari FN, et al. Low platelet count is associated with ductus arteriosus patency in preterm newborns. Early Hum Dev 2012; 88: 813-816
  6. Sallmon H, Weber SC, Hüning B, et al. Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus. Pediatrics 2012; 130: e623-e630
  7. Fujioka K, Morioka I, Miwa A, et al. Does thrombocytopenia contribute to patent ductus arteriosus? Nat Med 2011; 17: 29-30
  8. Dani C, Poggi C, Fontanelli G. Relationship between platelet count and volume and spontaneous and pharmacological closure of ductus arteriosus in preterm infants. Am J Perinatol 2013; 30: 359-364
  9. Antoniades HN. PDGF: A multifunctional growth factor. Baillieres Clin Endocrinol Metab 1991; 5: 595-613
  10. Bowen-Pope DF, Raines EW. History of discovery: platelet-derived growth factor. Arterioscler Thromb Vasc Biol 2011; 31: 2397-2401
  11. Hoch RV, Soriano P. Roles of PDGF in animal development. Development 2003; 130: 4769-4784
  12. Heldin CH, Ostman A, Rönnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1998; 1378: F79-F113
  13. Baumgartner HR, Hosang M. Platelets, platelet-derived growth factor and arteriosclerosis. Experientia 1988; 44: 109-112
  14. Li C, Li J, Li Y, et al. Crosstalk between platelets and the immune system: old systems with new discoveries. Adv Hematol 2012; 2012: 384685
  15. Coceani F, Baragatti B. Mechanisms for ductus arteriosus closure. Semin Perinatol 2012; 36: 92-97
  16. Bökenkamp R, DeRuiter MC, van Munsteren C, Gittenberger-de Groot AC. Insights into the pathogenesis and genetic background of patency of the ductus arteriosus. Neonatology 2010; 98: 6-17
  17. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate 2006; 89: 330-335
  18. Engür MA, Engür D. Platelet-rich plasma for patent ductus arteriosus: an orthopaedic surgeon's perspective. Cardiol Young 2014; 24: 385-387
  19. Lin F, Zhu J, Tonne